Loading...
XNAS
ZYXI
Market cap27mUSD
Dec 05, Last price  
0.89USD
1D
-13.59%
1Q
-40.27%
IPO
209.89%
Name

Zynex Inc

Chart & Performance

D1W1MN
XNAS:ZYXI chart
P/E
9.03
P/S
0.14
EPS
0.10
Div Yield, %
Shrs. gr., 5y
-2.87%
Rev. gr., 5y
33.44%
Revenues
192m
+4.36%
2,258,8082,556,8098,048,25211,763,55818,681,24224,085,00034,148,00039,666,00021,684,00011,117,00011,641,00013,313,00023,432,00031,917,00045,472,00080,122,000130,301,000158,167,000184,322,000192,354,000
Net income
3m
-69.24%
107,956-320,3702,131,350110,9522,382,312350,0001,564,0001,553,000-7,301,000-6,199,000-2,911,00069,0007,365,0009,552,0009,492,0009,074,00017,103,00017,048,0009,732,0002,994,000
CFO
13m
-28.36%
-217,058-483,460746,863-715,1603,648,024-665,000-362,000-879,000-382,000961,000341,0001,700,0008,260,0009,408,0006,303,000818,0006,949,00013,746,00017,756,00012,721,000
Dividend
Jan 05, 20220.1 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
IPO date
Nov 27, 2002
Employees
900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT